Uncategorized

Dear members of CMAG, In Sweden stakeholders have called for a general quality improvement of the hierarchy <<274035004 |Removal of urinary calculus (procedure)| Urologists points out that they find the hierarchy to be unstructured, with some concepts detailed and some are not. There is a lack of intermediate concepts. Many concepts are primitive. The suggestion is to better/more clearly divide children concepts after method (open/endoscopic). The endoscopic ones should be modelled

A request has been received regarding the terming of the concept 169826009 |Single live birth (finding)| as it could be interpreted to mean a single live birth from a singleton pregnancy or alternatively a single live birth from a multiple pregnancy. The requester suggested it be re-termed to make it clear it was from a singleton pregnancy. This concept has high usage when looking at UK usage data. The concept looks to be derived from ICD 10. In ICD Z37 Outcome of delivery has the exact wor

10756101000119107 |Group B streptococcus infection in mother complicating childbirth (disorder)| is stated as a child of 32801000119106 |Infectious disease in mother complicating childbirth (disorder)|, which makes it a descendant of 40733004 |Infectious disease (disorder)|. However, it has an acceptable synonym of "Group B streptococcus carrier in childbirth". So, carrier of B streptococcus in childbirth = to infection of streptococcus B in childbirth. Normally a carrier of a germ isn't

Hi, I'm struggling with the clinical differences and the differences in modeling between injury, wound and lesions. For example 'injury of breast' vs 'wound of breast' vs 'breast lesion'. Thank you for pointing this out. Kind regards, Katrien

Wherever a clinical drug concept in the International edition of SNOMED CT uses the term 'international unit' this will be replaced with the internationally recognized abbreviation IU without expansion of this abbreviation. The planned change will be made to 20 clinical drug concepts and the abbreviation IU will be noted as an exception in the Editorial Guide. Please add any comments or feedback to this page by no later than 30th June. Thank you

TNM content of the AJCC has been added to SNOMED in one of the last releases. In the Netherlands we miss some categories that are not used in the USA. If more countries needs this part as well we can ask them to add them to the international release. Else we are in contact with AJCC to be able to add them to our extension. It concerns codes for all possible ycT, ycN, rT, rN and rM categories Are there more countries that also use this part of the TNM categories and needs them in SNOMED? M

Some finding-concept got inactivated with only a replacement by a disorder-concept. For example '16386004 Dry skin (findig)' got replaced by 52475004 |Xeroderma (disorder)| ; The observation and identification of having a dry skin, doesn't always go together with a pathological condition (disorder). My question, is this inactivation temporary and will there be a replacement by a finding concept in the future?

The concept 704497002 |Uses British sign language interpreter (finding)| has been raised for inactivation at the international level. Prior to proceeding with this we are looking for the need for this concept outside of the UK. Would you please advise if British sign language is used in your country.

I'm wondering if other countries have guidelines for brand names in FSN? We more and more can't avoid the use of brand names in FSN, especially in lab domain. For example a KC type analyzer can give slightly different results depending on the brand used.  Our guidelines state not to use brand names in FSN, but I think we will come to exceptions on that guideline. I also read that Snomed Int will add vaccination brands to SNOMED (janssen&janssen, pfizer, astrazenica etc). How do other co

Are there any changes in the SNOMED Int./LOINC agreement or is it still difficult to have new Observables created in the terminology?